Progen Pharmaceuticals said that it had recently terminated its previous agreement with Global Transbiotech and was looking for a partner that could complete product development and commercialisation of
Mnemonics said that the tool helps in inspecting multiple-page documents including batch inspection of labels, catalogs, instruction manuals, long manuscripts, magazines. Mnemonics claimed that AVIA Infinity makes proofreading
Dow Chemical has posted a net income of $552m for the first quarter 2010, or $0.41 per diluted share, compared to $35m, or $0.03 per diluted share, for
The quality agreement template was created to provide guidance for drafting agreements relating to the manufacture and release of drug substances regulated by the FDA. The template is
The investigational new drug application (IND) was reviewed through SFDA’s Green Channel expedited application process. The first patients were dosed on April 28, 2010. Sulfatinib (HMPL-012) is a
Dendreon plans to have three plants to make Provenge by mid of 2011. According to an estimate by Bloomberg the drug is expected to generate $1.2bn by 2014.
Wyatt Technology said that DynaPro facilitated the detection of aggregation in early stages of micellisation of pluronic polymeric surfactant due to temperature effects, pH, salinity concentration and composition.
The license agreement is expected to enable Aragen Bioscience to offer its clients custom recombinant human cell lines expressing biotherapeutic proteins and antibodies as well as the transient
The ANDA, which was developed and registered by Granules, is in collaboration with Heritage Pharmaceuticals, a generic pharmaceutical company. Under a previous agreement, Heritage retains exclusive sales and
Panacea Biotec’s pharmaceutical formulation facility, spanning over 10,925m2, has blocks for oral solids, semi-solids and liquid oral dosage forms. The oral dosage form block has capability to manufacture
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.